These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 4156348)
41. [Effect of hyperbaric oxygenation on the microsomal enzymes of the liver monooxygenase system in the rat]. Smirnov IuV; Lukienko PI Farmakol Toksikol; 1983; 46(2):82-5. PubMed ID: 6852222 [TBL] [Abstract][Full Text] [Related]
42. [Purification and characterization of Linoleoyl-CoA desaturase from rat liver microsomes (author's transl)]. Okayasu T Hokkaido Igaku Zasshi; 1981 Jan; 56(1):43-54. PubMed ID: 7262818 [TBL] [Abstract][Full Text] [Related]
43. [Stabilization of reduced beta-nicotinamide-adenine-dinucleotide in an organic solvent (author's transl)]. Gallati H J Clin Chem Clin Biochem; 1976 Jan; 14(1):9-13. PubMed ID: 180231 [TBL] [Abstract][Full Text] [Related]
45. Further studies on the effects of metal ions on rat liver microsomal reduced nicotinamide adenine dinucleotide phosphate-cytochrome P-450 reductase. Fouts JR; Pohl RJ J Pharmacol Exp Ther; 1971 Oct; 179(1):91-100. PubMed ID: 4398541 [No Abstract] [Full Text] [Related]
46. High-affinity nitrosamine dealkylase system in rat liver microsomes and its induction by fasting. Tu YY; Yang CS Cancer Res; 1983 Feb; 43(2):623-9. PubMed ID: 6401221 [TBL] [Abstract][Full Text] [Related]
47. Reductase and oxygenase activities of semisynthetic flavocytochromes based on cytochrome P450 2B4. Shumyantseva VV; Uvarov VY; Byakova OE; Archakov AI Biochem Mol Biol Int; 1996 Apr; 38(4):829-38. PubMed ID: 8728113 [TBL] [Abstract][Full Text] [Related]
48. Role of Ser457 of NADPH-cytochrome P450 oxidoreductase in catalysis and control of FAD oxidation-reduction potential. Shen AL; Kasper CB Biochemistry; 1996 Jul; 35(29):9451-9. PubMed ID: 8755724 [TBL] [Abstract][Full Text] [Related]
49. Comparative studies on the oxidation and reduction of drug substrates in human placental versus rat hepatic microsomes. Juchau MR; Zachariah PK Biochem Pharmacol; 1975 Jan; 24(2):227-33. PubMed ID: 234233 [No Abstract] [Full Text] [Related]
50. Drug metabolism in liver tumors. Resolution of components and reconstitution of activity. Saine SE; Strobel HW Mol Pharmacol; 1976 Jul; 12(4):649-57. PubMed ID: 183097 [No Abstract] [Full Text] [Related]
51. A form of reduced nicotinamide adenine dinucleotide-cytochrome b 5 reductase containing both the catalytic site and an additional hydrophobic membrane-binding segment. Spatz L; Strittmatter P J Biol Chem; 1973 Feb; 248(3):793-9. PubMed ID: 4346350 [No Abstract] [Full Text] [Related]
52. Incorporation in vitro of purified cytochrome b 5 into liver microsomal membranes. Enomoto K; Sato R Biochem Biophys Res Commun; 1973 Mar; 51(1):1-7. PubMed ID: 4349323 [No Abstract] [Full Text] [Related]
53. Increase in anti-carboxylesterase action of organophosphorothioates by nicotinamide adenine dinucleotide (NAD) in vitro. Sugiyama S; Igarashi T; Ueno K; Satoh T; Kitagawa H Res Commun Chem Pathol Pharmacol; 1985 Jun; 48(3):455-8. PubMed ID: 4023425 [TBL] [Abstract][Full Text] [Related]
54. Inactivation of nitrate reductase by NADH in Nitrobacter agilis. Herrera J; Nicholas DJ Biochim Biophys Acta; 1974 Oct; 368(1):54-60. PubMed ID: 4154046 [No Abstract] [Full Text] [Related]
58. [A reductive enzymic ester cleavage of steroid acetates in the microsomal fraction of liver (author's transl)]. Dericks-Tan JS; Abraham R Hoppe Seylers Z Physiol Chem; 1974 Apr; 355(4):466-70. PubMed ID: 4154893 [No Abstract] [Full Text] [Related]
59. Mediation of reduced nicotinamide adenine dinucleotide phosphate dependent reduction of cytochrome c by morphine. Wang RI; Roerig DL Biochem Pharmacol; 1974 Nov; 23(22):3163-71. PubMed ID: 4155302 [No Abstract] [Full Text] [Related]
60. [The effect of C cytochrome and NADP on energetic ratio as indicator of psychic disorders (author's transl)]. Erban L; Hanzlícek L Cesk Psychiatr; 1974 Apr; 70(2):81-6. PubMed ID: 4155657 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]